je.st
news
Large 'pay for delay' fine imposed by CMA
2016-02-16 20:09:31| Biotech - Topix.net
On the 12th of February 2016, the UK Competition and Markets Authority fined GlaxoSmithKline and the successor companies to Alpharma Limited around 45m in total for breaches of Chapter I of the Competition Act 1998, the prohibition against anti-competitive agreements. The case shows the continued danger in pharmaceuticals reaching settlement agreements in IP disputes with generic drug providers.
Tags: large
pay
fine
delay
Category:Biotechnology and Pharmaceuticals